Amylin-Based Drugs Show Striking Weight Loss and Diabetes Remission in New Trials
A new review in Diabetes Therapy finds that three amylin-based agonists—zenagamtide, eloralintide and CagriSema—deliver unprecedented weight loss and, in some ...
Tag: CagriSema combination therapy
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!